These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3971843)

  • 1. Continuous intravenous insulin infusion in the management of brittle diabetes: etiologic and therapeutic implications.
    Williams G; Pickup JC; Keen H
    Diabetes Care; 1985; 8(1):21-7. PubMed ID: 3971843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous intraperitoneal insulin infusion in the management of severely brittle diabetes--a metabolic and clinical comparison with intravenous infusion.
    Husband DJ; Marshall SM; Walford S; Hanning I; Wright PD; Alberti KG
    Diabet Med; 1984 Jul; 1(2):99-104. PubMed ID: 6242795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise in insulin-dependent diabetes mellitus: the effect of continuous insulin infusion using the subcutaneous, intravenous, and intraperitoneal sites.
    Gooch BR; Abumrad NN; Robinson RP; Petrik M; Campbell D; Crofford OB
    Diabetes Care; 1983; 6(2):122-8. PubMed ID: 6343016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.
    Pickup J; Keen H
    Diabetes Care; 2002 Mar; 25(3):593-8. PubMed ID: 11874953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.
    Pickup JC; Home PD; Bilous RW; Keen H; Alberti KG
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):347-50. PubMed ID: 6780019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of Continuous Subcutaneous Insulin Infusion for Premature Neonate: A Case Report.
    Desenfants A; Soleirol M; Salet R; Benito Castro F; Le Guillou C; Di Maio M; Tran TA
    Neonatology; 2022; 119(2):260-263. PubMed ID: 35130548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of brittle diabetes.
    Williams G; Pickup JC
    Diabetes Res; 1988 Jan; 7(1):13-8. PubMed ID: 3042251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
    Buysschaert M; Lejeune M; Lambert AE
    Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
    Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
    Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin production rate in normal man as an estimate for calibration of continuous intravenous insulin infusion in insulin-dependent diabetic patients.
    Waldhäusl WK; Bratusch-Marrain PR; Francesconi M; Nowotny P; Kiss A
    Diabetes Care; 1982; 5(1):18-24. PubMed ID: 6754299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes.
    Selam JL; Slingeneyer A; Hedon B; Mares P; Beraud JJ; Mirouze J
    Diabetes Care; 1983; 6(2):105-11. PubMed ID: 6406198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brittle diabetes: long-term control with a portable, continuous, intravenous insulin infusion system.
    Bayliss J
    Br Med J (Clin Res Ed); 1981 Nov; 283(6301):1207-9. PubMed ID: 6797511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII.
    Home PD; Capaldo B; Burrin JM; Worth R; Alberti KG
    Diabetes Care; 1982; 5(5):466-71. PubMed ID: 6765222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical algorithm to determine the etiology of brittle diabetes.
    Schade DS; Eaton RP; Drumm DA; Duckworth WC
    Diabetes Care; 1985; 8(1):5-11. PubMed ID: 3882369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of extremely brittle, insulin-dependent diabetes with a novel subcutaneous insulin pump regimen.
    Nathan DM
    Diabetes Care; 1982; 5(2):105-10. PubMed ID: 6821487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus.
    Papargyri P; Ojeda Rodríguez S; Corrales Hernández JJ; Mories Álvarez MT; Recio Córdova JM; Delgado Gómez M; Sánchez Marcos AI; Iglesias López RA; Herrero Ruiz A; Beaulieu Oriol M; Miralles García JM
    Endocrinol Nutr; 2014 Mar; 61(3):141-6. PubMed ID: 24355548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diurnal variation in carbohydrate tolerance to mixed meal in insulin-dependent diabetic adolescents during continuous intravenous insulin infusion (CIVII).
    Rewers M; Dmochowski K; Walczak M
    Endokrynol Pol; 1985; 36(1):1-7. PubMed ID: 4042995
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of unstable diabetes with a portable insulin-infusion pump (author's transl)].
    Talaulicar M; Willms B
    Dtsch Med Wochenschr; 1982 Mar; 107(11):419-23. PubMed ID: 7037348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion.
    Patte C; Pleus S; Wiegel C; Schiltges G; Jendrike N; Haug C; Freckmann G
    Diabetes Technol Ther; 2013 Apr; 15(4):289-94. PubMed ID: 23427865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.